Keay Nakae
Stock Analyst at Chardan Capital
(3.99)
# 599
Out of 5,005 analysts
252
Total ratings
38.06%
Success rate
16.53%
Average return
Main Sectors:
Stocks Rated by Keay Nakae
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MNPR Monopar Therapeutics | Maintains: Buy | $60 → $85 | $99.39 | -14.48% | 4 | Sep 25, 2025 | |
| SABS SAB Biotherapeutics | Maintains: Buy | $12 | $2.06 | +482.52% | 17 | Sep 19, 2025 | |
| COYA Coya Therapeutics | Maintains: Buy | $14 | $6.10 | +129.50% | 21 | Sep 17, 2025 | |
| RNA Avidity Biosciences | Maintains: Buy | $75 | $47.00 | +59.57% | 19 | Sep 10, 2025 | |
| OBIO Orchestra BioMed Holdings | Maintains: Buy | $20 | $2.71 | +638.01% | 12 | Aug 13, 2025 | |
| KRRO Korro Bio | Maintains: Buy | $25 | $46.22 | -45.91% | 3 | Aug 13, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Buy | $60 | $36.12 | +66.11% | 20 | Aug 11, 2025 | |
| ABUS Arbutus Biopharma | Maintains: Buy | $5 | $4.38 | +14.16% | 13 | Aug 11, 2025 | |
| PRQR ProQR Therapeutics | Maintains: Buy | $4 | $2.45 | +63.27% | 15 | Aug 8, 2025 | |
| SLN Silence Therapeutics | Maintains: Buy | $35 | $5.00 | +600.00% | 13 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $325 → $400 | $456.35 | -12.35% | 14 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $38 | $13.06 | +190.96% | 13 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 | $0.86 | +481.73% | 5 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $1.25 → $6 | $20.59 | -70.86% | 10 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 | $5.63 | +255.24% | 14 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 | $1.92 | +212.50% | 7 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $2.5 | $2.03 | +23.15% | 6 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $0.63 | +1,169.64% | 10 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.66 | - | 5 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $8 → $6 | $18.41 | -67.41% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $20 | $0.52 | +3,761.00% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $55 | $9.15 | +501.09% | 10 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.25 → $10 | $4.17 | +139.81% | 5 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $100 → $88 | $15.49 | +464.88% | 2 | Sep 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $0.7 → $13 | $1.77 | +634.46% | 3 | Feb 9, 2021 |
Monopar Therapeutics
Sep 25, 2025
Maintains: Buy
Price Target: $60 → $85
Current: $99.39
Upside: -14.48%
SAB Biotherapeutics
Sep 19, 2025
Maintains: Buy
Price Target: $12
Current: $2.06
Upside: +482.52%
Coya Therapeutics
Sep 17, 2025
Maintains: Buy
Price Target: $14
Current: $6.10
Upside: +129.50%
Avidity Biosciences
Sep 10, 2025
Maintains: Buy
Price Target: $75
Current: $47.00
Upside: +59.57%
Orchestra BioMed Holdings
Aug 13, 2025
Maintains: Buy
Price Target: $20
Current: $2.71
Upside: +638.01%
Korro Bio
Aug 13, 2025
Maintains: Buy
Price Target: $25
Current: $46.22
Upside: -45.91%
Arrowhead Pharmaceuticals
Aug 11, 2025
Maintains: Buy
Price Target: $60
Current: $36.12
Upside: +66.11%
Arbutus Biopharma
Aug 11, 2025
Maintains: Buy
Price Target: $5
Current: $4.38
Upside: +14.16%
ProQR Therapeutics
Aug 8, 2025
Maintains: Buy
Price Target: $4
Current: $2.45
Upside: +63.27%
Silence Therapeutics
Aug 8, 2025
Maintains: Buy
Price Target: $35
Current: $5.00
Upside: +600.00%
Aug 1, 2025
Maintains: Buy
Price Target: $325 → $400
Current: $456.35
Upside: -12.35%
Jul 29, 2025
Maintains: Buy
Price Target: $50 → $38
Current: $13.06
Upside: +190.96%
Jun 25, 2025
Maintains: Buy
Price Target: $5
Current: $0.86
Upside: +481.73%
May 8, 2025
Downgrades: Neutral
Price Target: $1.25 → $6
Current: $20.59
Upside: -70.86%
Apr 7, 2025
Maintains: Buy
Price Target: $20
Current: $5.63
Upside: +255.24%
Mar 28, 2025
Maintains: Buy
Price Target: $6
Current: $1.92
Upside: +212.50%
Mar 27, 2025
Maintains: Neutral
Price Target: $2.5
Current: $2.03
Upside: +23.15%
Nov 13, 2024
Maintains: Buy
Price Target: $10 → $8
Current: $0.63
Upside: +1,169.64%
Feb 9, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.66
Upside: -
Aug 4, 2023
Maintains: Sell
Price Target: $8 → $6
Current: $18.41
Upside: -67.41%
Nov 10, 2022
Maintains: Buy
Price Target: $60 → $20
Current: $0.52
Upside: +3,761.00%
Nov 9, 2022
Maintains: Buy
Price Target: $65 → $55
Current: $9.15
Upside: +501.09%
Aug 16, 2022
Maintains: Neutral
Price Target: $1.25 → $10
Current: $4.17
Upside: +139.81%
Sep 20, 2021
Upgrades: Neutral
Price Target: $100 → $88
Current: $15.49
Upside: +464.88%
Feb 9, 2021
Downgrades: Neutral
Price Target: $0.7 → $13
Current: $1.77
Upside: +634.46%